Secondary hyperaldosteronism pathophysiology: Difference between revisions

	Secondary hyperaldosteronism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Secondary Hyperaldosteronism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT scan Findings
MRI Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Case Studies
Case #1
Secondary hyperaldosteronism pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Secondary hyperaldosteronism pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Secondary hyperaldosteronism pathophysiology
CDC on Secondary hyperaldosteronism pathophysiology
Secondary hyperaldosteronism pathophysiology in the news
Blogs on Secondary hyperaldosteronism pathophysiology
Directions to Hospitals Treating Conn syndrome
Risk calculators and risk factors for Secondary hyperaldosteronism pathophysiology

VisualWikitext

Latest revision as of 21:38, 28 September 2017

Overview

Secondary hyperaldosteronism is a disease of increasing aldosterone or other mineralocorticoid levels. The resulting Na+ retention produces hypertension, and elevated K+ excretion may cause hypokalemia.

Pathophysiology

Renin-angiotensin system components

Renin:

In each kidney there is a specialized system called juxtaglomerular apparatus, which is located in afferent arteriole of each glomerulus.
Juxtaglomerular apparatus synthesizes prorenin, and then later it converts into renin with mediation of a proteolytic enzyme.
Renin stores in and then may be released from secretory granules, in response to various factors.
Renin releasing starts a cascade of steps, and the first step is the cleavage of the angiotensin I from angiotensinogen (renin substrate).
Angiotensinogen is an alpha-2-globulin that is produced in the liver and kidney and other organs.
The first step is the rate-limiting step of the renin-angiotensin cascade.
Most important stimuli to renin secretion are :
- Renal hypoperfusion, due to hypotension or volume depletion
- Increased sympathetic activity.

Renin-angiotensin system components	Secretion control	Measurement
Renin	Baroreceptors (or stretch receptors) in the wall of the afferent arteriole Cardiac and arterial baroreceptors, which regulate sympathetic neural activity and the level of circulating catecholamines, both of which enhance renin secretion via the beta-1-adrenergic receptors The cells of the macula densa in the early distal tubule, which appear to be stimulated by a reduction in chloride delivery, particularly in the chloride concentration in the fluid delivered to this site	The plasma renin activity (PRA) is an indirect measure of renin that employs an enzyme-kinetic bioassay, which measures its capacity to generate angiotensin I. The rate of angiotensin I production, and therefore PRA, is critically dependent upon the concentration of substrate in plasma (ie, angiotensinogen). The plasma renin concentration (PRC) employs a direct immunosorbent assay that detects both prorenin and renin
Angiotensinogen
Angiotensin-converting enzyme
Angiotensin II
Aldosterone

Basic physiology of aldosterone

Circulating aldosterone is principally made in the zona glomerulosa of the adrenal cortex (outer layer of the cortex) by a cascade of enzyme steps leading to the conversion of cholesterol to aldosterone.

Aldosterone's production is regulated at two critical enzyme steps:
- (1) early in its biosynthetic pathway (the conversion of cholesterol to pregnenolone by cholesterol side chain cleavage enzyme) and
- (2) late (the conversion of corticosterone to aldosterone by aldosterone synthase).

A variety of factors modify aldosterone secretion--the most important are angiotensin II (AngII), the end-product of the renin-angiotensin system (RAS), and potassium. However ACTH, neural mediators and natriuretic factors also play part in the feedback mechanism.
Aldosterone's classical epithelial effect is to increase the transport of sodium across the cell in exchange for potassium and hydrogen ions. ^[1]

Renin angiotensin system, by Mikael Häggström - https://commons.wikimedia.org/w/index.php?curid=8458370

Adrenal steroid synthesis pathways in adrenal cortex and related enzymes ^[2]

Pathogenesis

Secondary hyperaldosteronism syndrome is a disease of increasing aldosterone or other mineralocorticoid levels. The resulting Na+ retention produces hypertension, and elevated K+ excretion may cause hypokalemia. Patients with Secondary hyperaldosertonism may have:

Genetics

References

↑ Williams GH (2005). "Aldosterone biosynthesis, regulation, and classical mechanism of action". Heart Fail Rev. 10 (1): 7–13. doi:10.1007/s10741-005-2343-3. PMID 15947886.
↑ "File:Adrenal Steroids Pathways.svg - Wikimedia Commons".

[pmid15947886-1] Williams GH (2005). "Aldosterone biosynthesis, regulation, and classical mechanism of action". Heart Fail Rev. 10 (1): 7–13. doi:10.1007/s10741-005-2343-3. PMID 15947886.

[urlFile:Adrenal_Steroids_Pathways.svg_-_Wikimedia_Commons-2] "File:Adrenal Steroids Pathways.svg - Wikimedia Commons".

[1]

[2]

@@ Line 5: / Line 5: @@
 == Pathophysiology ==
-Renin-angiotensin system components:
+=== Renin-angiotensin system components ===
-Renin
+[[Renin]]:
-* The afferent arteriole of each glomerulus contains specialized cells called the juxtaglomerular cells (figure 2). These cells synthesize the precursor, prorenin, which is cleaved into the active proteolytic enzyme, renin. Active renin is then stored in and released from secretory granules [9,10]. Renin initiates a sequence of steps that begins with cleavage of the decapeptide, angiotensin I, from renin substrate (angiotensinogen [AGT]), an alpha-2-globulin produced in the liver (and other organs including the kidney) [11,12]. This first step is also the rate-limiting step of the RAS cascade. Renal hypoperfusion, caused by hypotension or volume depletion, and increased sympathetic activity are the major physiologic stimuli to renin secretion (figure 3).
+* In each [[kidney]] there is a specialized system called [[juxtaglomerular apparatus]], which is located in [[afferent arteriole]] of each [[glomerulus]].
+* [[Juxtaglomerular apparatus]] synthesizes prorenin, and then later it converts into [[renin]] with mediation of a [[proteolytic enzyme]].
+* [[Renin]] stores in and then may be released from secretory [[granules]], in response to various factors.
+* [[Renin]] releasing starts a cascade of steps, and the first step is the cleavage of the [[angiotensin]] I from  [[angiotensinogen]] ([[renin]] substrate).
+* [[Angiotensinogen]] is an alpha-2-globulin that is produced in the [[liver]] and [[kidney]] and other organs.
+* The first step is the rate-limiting step of the [[Renin-angiotensin system|renin-angiotensin]] cascade.
+* Most important stimuli to [[renin]] secretion are :
+** [[Renal]] hypoperfusion, due to hypotension or [[volume depletion]]
+** Increased [[sympathetic]] activity.
 {| class="wikitable"
@@ Line 59: / Line 67: @@
-[[Image:Renin-angiotensin system in man shadow.png|600px|center|Renin angiotensin system, by Mikael Häggström - https://commons.wikimedia.org/w/index.php?curid=8458370]]
+[[Image:Renin-angiotensin system in man shadow.png|600px|center|thumb|Renin angiotensin system, by Mikael Häggström - https://commons.wikimedia.org/w/index.php?curid=8458370]]